Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 910

Results For "C"

9098 News Found

Indian pharma industry registers 18% exports growth: Narendra Modi
Policy | April 20, 2021

Indian pharma industry registers 18% exports growth: Narendra Modi

Essential medicines were made available to more than 150 countries around the world during the pandemic


GlaxoSmithKline approves sale of Vemgal plant
News | April 05, 2021

GlaxoSmithKline approves sale of Vemgal plant

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS


Bliss GVS Pharma files suit for IPR infringement
News | March 30, 2021

Bliss GVS Pharma files suit for IPR infringement

The company had filed a suit in the High Court of Justice, Ghana


LupinLife to promote hand hygiene at Kumbh Mela 2021
News | March 24, 2021

LupinLife to promote hand hygiene at Kumbh Mela 2021

Lupin will provide five lakh LupiSafe hand sanitizers to policemen and frontline workers deployed at strategic locations


Indian Pharma market to grow to US$ 130 bn by 2030: Gowda
News | February 11, 2021

Indian Pharma market to grow to US$ 130 bn by 2030: Gowda

The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.


Laurus Q3 FY21 revenue up 76%; PAT grows 274%
News | January 29, 2021

Laurus Q3 FY21 revenue up 76%; PAT grows 274%

The company has concluded our acquisition of Richcore Lifesciences on 20th Jan 2021.


Lonza reports 12% sales growth in 2020
News | January 28, 2021

Lonza reports 12% sales growth in 2020

Lonza maintained business continuity during the COVID-19 pandemic with minimal impacts to operations and supply throughout 2020.


Dr. Reddy’s gets approval for Sputnik V Phase 3 trial
News | January 16, 2021

Dr. Reddy’s gets approval for Sputnik V Phase 3 trial

The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.